scholarly journals A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19

2021 ◽  
Vol 7 (3) ◽  
pp. 174
Author(s):  
Anubhav Kanwar ◽  
Alex Jordan ◽  
Scott Olewiler ◽  
Kurt Wehberg ◽  
Michael Cortes ◽  
...  
Keyword(s):  
Fatal Case ◽  
Hospitalized Patients ◽  
Pulmonary Aspergillosis

We report a fatal case of Rhizopus azygosporus pneumonia in a 56-year-old man hospitalized for COVID-19 who had received methylprednisolone and tocilizumab. Although COVID-associated pulmonary aspergillosis has been widely documented, mucormycosis has been rarely reported. In this patient, receipt of two commonly used immunosuppressants likely contributed to mucormycosis risk, suggesting the need for vigilance in hospitalized patients with COVID-19.

scholarly journals A fatal case of COVID-19-associated invasive pulmonary aspergillosis

2021 ◽  
Author(s):  
Yuto Iwanaga ◽  
Toshinori Kawanami ◽  
Kei Yamasaki ◽  
Hideki Sakakibara ◽  
Issei Ikusima ◽  
...  
Keyword(s):  
Fatal Case ◽  
Invasive Pulmonary Aspergillosis ◽  
Pulmonary Aspergillosis

scholarly journals Fatal Case of Chronic Pulmonary Aspergillosis and Tuberculosis: A Case Report from an University Hospital in Colombia

2020 ◽  
Author(s):  
Carlos Andres Celis-Preciado ◽  
July Torres-González ◽  
Lina Arbelaez-Collazos ◽  
Camila Betancur-Palacio ◽  
Óscar David Lucero Pantoja
Keyword(s):  
Soft Tissues ◽  
Fatal Case ◽  
Allergic Bronchopulmonary Aspergillosis ◽  
Left Lung ◽  
Middle Lobe ◽  
University Hospital ◽  
Pulmonary Aspergillosis ◽  
Pleural Thickening ◽  
Chronic Respiratory Diseases ◽  
Chronic Pulmonary Aspergillosis

Abstract BackgroundThe term aspergillosis from a clinical point of view includes allergic bronchopulmonary aspergillosis, invasive forms of the airway, cutaneous and extrapulmonary aspergillosis and finally chronic non-invasive or semi-invasive pulmonary forms. All of them produced by different species of Aspergillus. In addition, the presentation of aspergillosis together with tuberculosis are rare in scientific literature. We report a case of Chronic pulmonary aspergillosis and tuberculosis in a 72-year-old man Case presentation The patient is a 72-year-old man who was admitted with a 2-year history of constitutional syndrome, dry cough and moderate exertion dyspnea. Chest X-ray showed a rounded mass in the upper lobe of the left lung surrounded by radiolucent areas that suggest cavitations. Computed tomography with chest contrast revealed "tree in bud" pattern in the upper right and middle lobe and lesions of a cystic appearance with the presence of multiple masses with a density of soft tissues. Bronchioalveolar lavage analyses demonstrate Aspergillus fumigatusConclusionsChronic cavity aspergillosis is an uncommon form characterized by cavitation, fibrosis and pleural thickening seen in immunocompetent or mildly immunocompromised patients with chronic respiratory diseases, especially TB.

scholarly journals 987. Clinical Epidemiology and Outcomes of Invasive Pulmonary Aspergillosis as a Complication of Respiratory Viral Infection in Hospitalized Patients

2021 ◽  
Vol 8 (Supplement_1) ◽  
pp. S584-S584
Author(s):  
Bertha A De Los Santos ◽  
Brian J Barnes ◽  
Nicholas Britt
Keyword(s):  
Kansas City ◽  
Viral Infections ◽  
Clinical Epidemiology ◽  
Invasive Pulmonary Aspergillosis ◽  
Hospitalized Patients ◽  
Pulmonary Aspergillosis ◽  
All Cause Mortality ◽  
Syncytial Virus ◽  
One Year ◽  
The University

Abstract Background Invasive pulmonary aspergillosis (IPA) is increasingly recognized as a complication of severe respiratory viral infections (RVIs), including influenza and COVID-19. However, the incidence and outcomes of IPA following other RVIs is not well-described. We hypothesized that IPA may be an underreported complication of non-influenza RVIs. The objective of this study was to quantify the incidence and associated outcomes of IPA following RVI in hospitalized patients. Methods We conducted a single-center retrospective cohort study of adult hospitalized patients with RVI diagnosed by multiplex PCR-based assay at the University of Kansas Hospital (Kansas City, Kansas) from September 2018-October 2019. Patients with a diagnosis of proven or probable IPA prior to RVI and those with hospital admission < 24 h were excluded from analysis. Proven or probable IPA was defined according to EORTC/MSGERC consensus definitions. The primary outcome was 1-year all-cause mortality. Results A total of 195 patients met study criteria and were included in the analysis. The most common types of RVI observed were rhinovirus/enterovirus (57.9%, n=113), parainfluenza (13.3%, n=26), influenza (8.2%, n=16), and respiratory syncytial virus (7.7%, n=15). The cumulative incidence of IPA infection within 6 weeks of RVI was 5.6% (n=11). Excluding patients co-infected with multiple respiratory viruses (n=5), IPA was numerically more likely to occur following influenza compared to non-influenza RVI (12.5% [ n=2/16] vs. 4.6% [n=8/174]; odds ratio, 2.96; 95% confidence interval [CI], 0.57-15.3; P=0.176). Overall, one-year all-cause mortality was 20% (n=39/195) in this cohort. Development of IPA as a complication of RVI was associated with a significant decrease in 1-year survival (hazard ratio [HR], 3.04; 95% CI, 1.19-7.78; P=0.021), and this relationship persisted after adjustment for age (HR, 2.77; 95% CI, 1.08-7.10; P=0.034). Conclusion In a cohort of hospitalized patients with RVI, 5.6% of patients developed proven or probable IPA. Although IPA was more likely to occur in patients with influenza, this complication was also observed with other types of RVI. Invasive pulmonary aspergillosis may be an underappreciated complication of non-influenza RVI in hospitalized patients and warrants continued study. Disclosures All Authors: No reported disclosures

589 Quality of heart failure diagnosis in hospitalized patients

2003 ◽  
Vol 2 (1) ◽  
pp. 128-129
Author(s):  
P SARMENTO ◽  
C FONSECA ◽  
F MARQUES ◽  
J NUNES ◽  
F CEIA
Keyword(s):  
Heart Failure ◽  
Hospitalized Patients ◽  
Failure Diagnosis ◽  
Heart Failure Diagnosis

Anticoagulation in Hospitalized Patients

2009 ◽  
Vol 2 (4) ◽  
pp. 3
Author(s):  
AMIR K. JAFFER
Keyword(s):  
Hospitalized Patients
Sign in / Sign up

Export Citation Format

Share Document